« Back
Home /
Bevacizumab

Bevacizumab

Item no.	TMO-T9904-2mg
Manufacturer	TargetMol
CASRN	216974-75-3
Amount	2 mg
Quantity options	10mg 1 mg 25mg 2 mg 50mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Purity	0,98
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	VEGFR
Shipping condition	Cool pack
Available
Manufacturer - Targets	VEGFR
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	149 kDa
Description	Bevacizumab, a humanized monoclonal antibody, specifically and with high affinity binds to all isoforms of VEGF-A.
Bioactivity	Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
Pathways	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2 mg

available

Delivery expected until 1/31/2025